Principal Scientist

Business Introduction

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting‑edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success.

We’re uniting science, technology, and talent to get ahead of disease together.

Our approach to R&D

Are you a scientist in sterile drug product development eager to lead the development of life‑changing drug products? Are you eager to unite science, talent, and technology to get ahead of disease together? This may be the right opportunity for you! Formulation and Process Development, within the Drug Product Development (DPD) department, is part of the wider R&D Drug Development and Supply organization, and is a highly experienced Chemistry, Manufacturing and Controls (CMC) organization accountable for delivering robust, cost effective and competitive product and manufacturing processes spanning the full life‑cycle of asset development from discovery through commercialization.

These activities are delivered through state‑of‑the‑art internal facilities as well as strategic external partners. Collectively, the team is accountable for CMC activities encompassing both small molecule and large molecule (biopharma) drug product development. We also pioneer innovative technologies and employ data science to improve robustness, reduce cost of goods, and improve the patient experience. Within Drug Product Development (DPD), the Formulation and Process Development (FPD) department focuses on developing world class patient‑centric biopharmaceutical and small‑molecule drug products through innovation, technology and strategic partnering.

The successful candidate for this position will focus on biopharmaceutical drug product development for protein (e.g., mAbs, bispecific mAbs, antibody‑drug‑conjugates (ADCs)) and peptide‑based therapeutics. This role will focus on drug product development for assets being developed for Clinical Phases 2 and 3, and commercialization. Associated activities may include protein formulation optimization and development stability assessment, in‑use compatibility/stability assessments to support product administration, drug product process development, characterization, and technical transfer activities to a GMP manufacturing facility.

We are looking for professionals with these required skills to achieve our goals:

• PhD degree in Pharmaceutical Sciences, Chemistry, Biochemistry, Biology, Bioengineering, Biomedical engineering, or Chemical Engineering with 0+ years of protein formulation and/or process development or, MS degree with 5+ years of industry experience; or, BS degree with 7+ years of industry experience.
• Experience in authoring technical documents.

• Experience working with antibody‑drug‑conjugates (ADCs).
• Experience or ability to interpret results from multiple bioanalytical techniques for product characterization and product stability evaluation.
• Experience with both conventional and alternative biopharmaceutical protein formulation and drug product stability evaluation, including the application of DOE and other statistically based experimental design/interpretation approaches.
• Experience with protein drug product manufacturing processes and development (e.g., solution in vial/PFS, or lyophilization); container/closure assessment & selection, drug delivery (e.g., combination product, device & administration kit) feasibility and compatibility evaluation.
• Experience with biophysical techniques for product characterization and stability evaluation is valuable, e.g., DSC, DSF (experience with Uncle or Prometheus Panta), particles size evaluation (MFI, Flow Cam), light scattering, etc.
• Experience in authoring regulatory…